HR, hazard ratio; CI, confidence interval; PBSC, peripheral blood stem cells; BM, bone marrow; TBI, total body irradiation.
Univariate | Multivariate | |||
HR (95% CI) | P value | HR (95% CI) | P value | |
Antibiotic treatment group | ||||
Imipenem/piperacillin- tazobactam | Reference | Reference | ||
Aztreonam/cefepime | 0.38 (0.15–0.94) | 0.037 | 0.4 (0.16–0.99) | 0.048 |
Age >40 | 1.35 (0.69–2.64) | 0.38 | ||
Race | ||||
White/Black | Reference | |||
Asian/Hispanic | 1.19 (0.56–2.53) | 0.65 | ||
Other | 1.89 (0.64–5.57) | 0.25 | ||
Source | ||||
PBSC | Reference | |||
BM | 1.27 (0.44–3.72) | 0.66 | ||
Cord | 1.21 (0.69–2.11) | 0.51 | ||
Donor | ||||
Sibling identical | Reference | |||
Unrelated identical | 1.47 (0.64–3.35) | 0.36 | ||
Nonidentical | 2.08 (0.96–4.47) | 0.062 | ||
Intensity | ||||
Ablative | Reference | Reference | ||
Reduced | 1.03 (0.49–2.19) | 0.93 | 1.04 (0.49–2.2) | 0.920 |
Nonablative | 2.37 (1.15–4.91) | 0.020 | 2.3 (1.11–4.76) | 0.026 |
TBI (any) | 1.72 (0.92–3.22) | 0.087 |